MILWAUKEE: Study shows cost of multiple sclerosis drugs increased five to seven times greater than prescription drug inflation, with researchers voicing concern over patient access to life-changing treatments.
A new study shows an ‘alarming rise’ over the last 20 years in the costs of drugs used to slow the progression of multiple sclerosis or reduce the frequency of attacks…